MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $34,000 | -89.1% | 27,500 | -72.9% | 0.00% | -100.0% |
Q1 2017 | $312,000 | +47.9% | 101,400 | +95.4% | 0.01% | +66.7% |
Q4 2016 | $211,000 | +229.7% | 51,900 | +408.8% | 0.00% | +200.0% |
Q3 2016 | $64,000 | +1500.0% | 10,200 | +18114.3% | 0.00% | – |
Q3 2015 | $4,000 | -85.7% | 56 | -90.7% | 0.00% | -100.0% |
Q1 2015 | $28,000 | -65.9% | 600 | -14.3% | 0.00% | -50.0% |
Q4 2014 | $82,000 | +67.3% | 700 | -59.4% | 0.00% | +100.0% |
Q3 2014 | $49,000 | -76.7% | 1,724 | -46.9% | 0.00% | -80.0% |
Q2 2014 | $210,000 | +36.4% | 3,248 | -35.7% | 0.01% | +66.7% |
Q1 2014 | $154,000 | +51.0% | 5,053 | +823.8% | 0.00% | +50.0% |
Q4 2013 | $102,000 | – | 547 | +2504.8% | 0.00% | – |
Q3 2013 | $0 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |